Kolkata, New Delhi, INDIA. New York, USA.
Business To Business, New Delhi, 28 October 2025: In the third quarter ending September 2023, India's pharmaceutical and healthcare sector saw a total of 72 transactions valued at approximately USD 3.5 billion, according to Grant Thornton Bharat's Dealtracker.
The deal activity included three IPOs with a combined value of USD 428 million and one Qualified Institutional Placement (QIP) worth USD 88 million. Excluding public market activities, private deals comprised around USD 3 billion across 68 transactions, indicating a significant rebound in investor interest in the sector.